03/24/2020
3:19 PM | Theravance Biopharma (Filer)
| Form DEF 14A
| |
03/09/2020
3:31 PM | BlackRock Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A
| |
03/04/2020
3:55 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2020
6:16 PM | Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:15 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:13 PM | Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:12 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:11 PM | PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:10 PM | PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:08 PM | Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:07 PM | HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2020
6:05 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2020
5:02 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2020
3:21 PM | Theravance Biopharma (Filer)
| Form 424B5
| |
02/06/2020
8:23 AM | BlackRock Inc. (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G/A
| |
02/05/2020
6:07 PM | Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
6:06 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
6:05 PM | Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
6:04 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
6:02 PM | PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
6:00 PM | PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
5:58 PM | Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
5:57 PM | HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
5:55 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
8:49 AM | Theravance Biopharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G
| |
01/13/2020
7:15 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2020
4:20 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2019
3:51 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2019
5:09 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2019
5:02 PM | Theravance Biopharma (Filer)
| Form S-3ASR
| |
11/22/2019
5:28 PM | Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:26 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:25 PM | Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:24 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:23 PM | PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:22 PM | PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:20 PM | HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2019
5:18 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2019
2:01 PM | Theravance Biopharma (Subject)
Woodford Investment Management Ltd (Filed by)
| Form SC 13G/A
| |
11/08/2019
5:17 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2019
3:45 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2019
7:09 AM | Link Fund Solutions Ltd (Filed by)
Theravance Biopharma (Subject)
| Form SC 13G
| |
09/30/2019
7:00 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2019
6:10 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2019
6:06 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2019
5:08 PM | Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:07 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:06 PM | Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:05 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:03 PM | PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:02 PM | PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:01 PM | HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
5:00 PM | HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2019
4:58 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
10:48 AM | Theravance Biopharma (Filer)
| Form CT ORDER
| |
08/05/2019
3:31 PM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2019
6:10 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2019
5:05 PM | Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2019
8:15 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2019
7:16 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2019
4:47 PM | Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2019
8:22 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2019
5:19 PM | Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:17 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:15 PM | Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:13 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:11 PM | PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:09 PM | PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:07 PM | HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:05 PM | HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
5:03 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
5:02 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2019
8:02 AM | Theravance Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2019
5:11 AM | Theravance Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019
3:52 PM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2019
5:44 PM | Molineaux Susan (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:36 PM | Theravance Biopharma (Issuer)
YOUNG WILLIAM D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:34 PM | Theravance Biopharma (Issuer)
WHITESIDES GEORGE M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:32 PM | RINGROSE PETER S (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:28 PM | O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:23 PM | MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:21 PM | MALKIEL BURTON G (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:17 PM | Gunderson Robert V JR (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:14 PM | BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
5:11 PM | Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2019
7:30 AM | Theravance Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2019
9:49 AM | GLAXOSMITHKLINE PLC (Filed by)
Theravance Biopharma (Subject)
| Form SC 13D/A
| |
03/20/2019
4:18 PM | Theravance Biopharma (Filer)
| Form DEF 14A
| |
03/06/2019
6:20 PM | HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:27 PM | Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:25 PM | Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:23 PM | SULIMAN SHEHNAAZ (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:22 PM | Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:20 PM | SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:18 PM | PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:16 PM | PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:15 PM | HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:13 PM | HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2019
5:11 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2019
5:15 PM | BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
